Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Da-Qiang Li

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Autophagy|August 3, 2022
TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progressionTai-Mei Zhang, Li Liao, Shao-Ying Yang, et al.
Science Advances|April 3, 2024
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1Ling Deng, Li Liao, Yin-Ling Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesisDa-Qiang Li, Suresh B Pakala, Sirigiri Divijendra Natha Reddy, et al.
Cancer Cell|July 4, 2009
EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with AktHui Miao, Da-Qiang Li, Amitava Mukherjee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 23, 2025
MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast CancerYin-Ling Zhang, Min-Ying Huang, Shao-Ying Yang, et al.
Molecular Cancer|May 29, 2026
Targeting MORC2 activates transposable element-mediated viral mimicry and potentiates immune checkpoint blockade in triple-negative breast cancerFang-Lin Zhang, Shao-Ying Yang, Yin-Ling Zhang, et al.
Theranostics|February 16, 2023
Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancerFang-Lin Zhang, Shao-Ying Yang, Li Liao, et al.
Clinical and Translational Medicine|May 6, 2022
HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progressionFan Yang, Rui Sun, Zeng Hou, et al.
Cell Death and Differentiation|August 14, 2019
RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2Yin-Long Yang, Ye Zhang, Dou-Dou Li, et al.
Proteomics|April 26, 2006
Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometryDa-Qiang Li, Lei Wang, Fei Fei, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Autophagy|August 3, 2022
TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progressionTai-Mei Zhang, Li Liao, Shao-Ying Yang, et al.
Science Advances|April 3, 2024
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1Ling Deng, Li Liao, Yin-Ling Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesisDa-Qiang Li, Suresh B Pakala, Sirigiri Divijendra Natha Reddy, et al.
Cancer Cell|July 4, 2009
EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with AktHui Miao, Da-Qiang Li, Amitava Mukherjee, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 23, 2025
MYC/TET3-Regulated TMEM65 Activates OXPHOS-SERPINB3 Pathway to Promote Progression and Cisplatin Resistance in Triple-Negative Breast CancerYin-Ling Zhang, Min-Ying Huang, Shao-Ying Yang, et al.
Molecular Cancer|May 29, 2026
Targeting MORC2 activates transposable element-mediated viral mimicry and potentiates immune checkpoint blockade in triple-negative breast cancerFang-Lin Zhang, Shao-Ying Yang, Yin-Ling Zhang, et al.
Theranostics|February 16, 2023
Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancerFang-Lin Zhang, Shao-Ying Yang, Li Liao, et al.
Clinical and Translational Medicine|May 6, 2022
HSP90 N-terminal inhibitors target oncoprotein MORC2 for autophagic degradation and suppress MORC2-driven breast cancer progressionFan Yang, Rui Sun, Zeng Hou, et al.
Cell Death and Differentiation|August 14, 2019
RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2Yin-Long Yang, Ye Zhang, Dou-Dou Li, et al.
Proteomics|April 26, 2006
Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometryDa-Qiang Li, Lei Wang, Fei Fei, et al.
Pageof 11